155 related articles for article (PubMed ID: 6376558)
21. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
22. Membrane associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells.
Seibert E; Sorg C; Happle R; Macher E
Int J Cancer; 1977 Feb; 19(2):172-8. PubMed ID: 402317
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
[TBL] [Abstract][Full Text] [Related]
24. Clinical comparison of desonide cream with fluocinonide cream in steroid-responsive dermatologic disorders.
Barsky S
Cutis; 1976 Dec; 18(6):826-30. PubMed ID: 797554
[TBL] [Abstract][Full Text] [Related]
25. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
[TBL] [Abstract][Full Text] [Related]
27. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
Okamoto T; Irie RF; Fujii S; Huang SK; Nizze AJ; Morton DL; Hoon DS
J Invest Dermatol; 1998 Dec; 111(6):1034-9. PubMed ID: 9856813
[TBL] [Abstract][Full Text] [Related]
28. Immunological basis of melanoma-associated vitiligo-like depigmentation.
González R; Torres-López E
Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
[TBL] [Abstract][Full Text] [Related]
29. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
Shimao S
J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
[No Abstract] [Full Text] [Related]
30. Vitiligo-related pigment cell differentiation antigens are expressed on malignant melanoma cells following phenotypic reversion induced by contact inhibitory factor.
Lipkin G; Naughton GK; Rosenberg M; Bystryn JC
Differentiation; 1985; 30(1):35-9. PubMed ID: 3912244
[TBL] [Abstract][Full Text] [Related]
31. Expression of vitiligo antigen on a revertant line of hamster melanoma cells.
Naughton GK; Lipkin G; Bystryn JC
J Invest Dermatol; 1984 Nov; 83(5):317-9. PubMed ID: 6386993
[TBL] [Abstract][Full Text] [Related]
32. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
Cornell RC
Cutis; 1983 May; 31(5):566-9. PubMed ID: 6851655
[TBL] [Abstract][Full Text] [Related]
33. The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.
Teulings HE; Willemsen KJ; Glykofridis I; Krebbers G; Komen L; Kroon MW; Kemp EH; Wolkerstorfer A; van der Veen JP; Luiten RM; Tjin EP
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1086-96. PubMed ID: 25043574
[TBL] [Abstract][Full Text] [Related]
34. Vitiligo: peripheral T-cell subset imbalance as defined by monoclonal antibodies.
Soubiran P; Benzaken S; Bellet C; Lacour JP; Ortonne JP
Br J Dermatol; 1985 Jul; 113 Suppl 28():124-7. PubMed ID: 3893518
[No Abstract] [Full Text] [Related]
35. A controlled clinical trial of the efficacy of topically applied fluocinonide in the treatment of recurrent aphthous ulceration.
Pimlott SJ; Walker DM
Br Dent J; 1983 Mar; 154(6):174-7. PubMed ID: 6342633
[No Abstract] [Full Text] [Related]
36. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
[No Abstract] [Full Text] [Related]
37. [Scabies].
Fernández T; de Fernández CC
Rev Ecuat Hig Med Trop; 1977; 30(1):47-56. PubMed ID: 607327
[No Abstract] [Full Text] [Related]
38. Melanoma-associated leukoderma - immunology in black and white?
Naveh HP; Rao UN; Butterfield LH
Pigment Cell Melanoma Res; 2013 Nov; 26(6):796-804. PubMed ID: 24010963
[TBL] [Abstract][Full Text] [Related]
39. Adult-onset leukoderma and malignant melanoma.
Gross DJ; Singer PG; Schosser RH
Arch Dermatol; 1990 Sep; 126(9):1240-1. PubMed ID: 2396849
[No Abstract] [Full Text] [Related]
40. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.
Rosenberg SA; White DE
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):81-4. PubMed ID: 8859727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
